RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival.
about
Inhibition of regulated cell death by cell-penetrating peptidesNecroptosis in acute kidney injury: a shedding lightNecroptosis: an emerging type of cell death in liver diseasesOxidative stress-mediated HMGB1 biologyRole of necroptosis in the pathogenesis of solid organ injuryEmerging therapies targeting intra-organ inflammation in transplantationA cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis.Molecular and cellular mechanisms responsible for cellular stress and low-grade inflammation induced by a super-low dose of endotoxinNecroptosisFight or flight: regulation of emergency hematopoiesis by pyroptosis and necroptosis.HMGB1 in health and disease.What's new in clinical solid organ transplantation by 2013.Receptor interacting protein 3-induced RGC-5 cell necroptosis following oxygen glucose deprivation.Hypothermic machine perfusion increases A20 expression which protects renal cells against ischemia/reperfusion injury by suppressing inflammation, apoptosis and necroptosis.Exogenous Lipocalin 2 Ameliorates Acute Rejection in a Mouse Model of Renal TransplantationNecroptosis in immunity and ischemia-reperfusion injury.Interaction between systemic inflammation and renal tubular epithelial cells.The expression of HMGB1 on microparticles released during cell activation and cell death in vitro and in vivo.Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis.Immune system modulation of kidney regeneration--mechanisms and implications.Programmed necrosis and necroptosis signalling.The diverse role of RIP kinases in necroptosis and inflammation.Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment.Necroinflammation in Kidney Disease.Recent early clinical drug development for acute kidney injury.Necroptosis: A Novel Cell Death Modality and Its Potential Relevance for Critical Care Medicine.Prolonged Ischemia Triggers Necrotic Depletion of Tissue-Resident Macrophages To Facilitate Inflammatory Immune Activation in Liver Ischemia Reperfusion Injury.Pharmacological modulation of cell death in organ transplantation.Necroptosis: Mechanisms and Relevance to Disease.Intracellular pH Regulates TRAIL-Induced Apoptosis and Necroptosis in Endothelial Cells.Die later with ESCRT!CXCR₄antagonism as a therapeutic approach to prevent acute kidney injury.miR-200a-5p regulates myocardial necroptosis induced by Se deficiency via targeting RNF11.Necroptosis in microglia contributes to neuroinflammation and retinal degeneration through TLR4 activation.Necrostatin-1 Protects Against D-Galactosamine and Lipopolysaccharide-Induced Hepatic Injury by Preventing TLR4 and RAGE Signaling.Receptor-Interacting Protein Kinases 1 and 3, and Mixed Lineage Kinase Domain-Like Protein Are Activated by Sublytic Complement and Participate in Complement-Dependent Cytotoxicity.RIPK3-mediated necroptosis regulates cardiac allograft rejection.Necrostatin-1 Attenuates Cisplatin-Induced Nephrotoxicity Through Suppression of Apoptosis and Oxidative Stress and Retains Klotho Expression.Endothelial Dysfunction in Kidney Transplantation.HMGB1 released from intestinal epithelia damaged by cholera toxin adjuvant contributes to activation of mucosal dendritic cells and induction of intestinal cytotoxic T lymphocytes and IgA.
P2860
Q26751423-1A0AF406-46B5-4348-A4F7-DDDF73DA5BA5Q26764791-52FE580F-23B3-4DBE-89BA-8A51998D93CAQ26849790-D66694A5-F6AC-4664-B568-C70E0006982EQ27000955-1CF4D031-B5AC-416F-B920-2CA6341803C1Q27023218-3814904C-948C-426A-B5EE-EB3399CEB271Q28085496-18157BF6-1232-4DD2-9115-7840C86D1FC3Q30396736-4B53B7D6-AB59-44FE-91A7-7E1497D2E937Q33718511-C095D8E6-8A42-497B-8381-3A365535434DQ34039704-41ECE47F-AA5D-4134-9853-05A5EFD2B5E1Q34044175-E6BC95E2-F5BB-4CE7-BF9F-FBD05DD500CFQ34622835-28D77EC5-E2BD-4D11-8FCB-0DA88E4D84D2Q34761349-CC2E6EC0-4924-4B2F-82AA-DF69E2A532FEQ35736069-341F33AE-DF88-4F39-BAFD-D6B21CB12E79Q36983748-55F8A1E3-A970-4B98-9772-AF93F6035CDCQ37200856-AD1E38D0-CA83-4FA0-BB60-A484F5A799FAQ38150511-714E2CEA-3245-488A-99EE-D56E49F4DBC7Q38192855-D4B89029-7C2C-4C74-948B-ACD513F9EC11Q38195181-CB0E4801-FB21-47A4-84BD-4D538C7481ABQ38206875-94AE5BDA-8CA6-4834-9B54-EAF68A8F43E6Q38207847-6806A0DF-5B1A-452F-BC80-1406C2A5296BQ38261258-74D5B8E0-9ABF-4A2A-ADAF-45AA04027BFFQ38530866-3CF8B611-B542-431E-963D-451FA3875C9CQ38541350-FCEB94BF-4382-4D07-A36E-738D2E63346BQ38579499-F548B316-5088-489E-ABE0-B27C400B6B62Q38780169-0D3C7C41-76CD-4A3B-820C-8692EF7B97E3Q38861198-3E9F2DB6-1A52-4602-A5C0-6EB71BE005ECQ38910411-1B511803-696E-40FB-BCD1-FE2A4B20AC81Q39290025-AAA3857D-DA33-4039-99AC-13F48DBD6714Q40411907-96683270-E4C4-48F2-B08B-507DB4151ACFQ41528739-0A09966A-8AFA-4630-AEE8-EC71D247BF46Q42335688-8BDD4B65-B633-47E3-A502-D5B7C97A54CFQ45419445-9148ECAF-F315-4B4C-96D6-952DDEAD5972Q47242642-F99C63C8-E431-43D7-A573-EC255F119842Q47373746-05DA53C1-793C-4BDD-A03C-B9CFD44BB4A0Q48018174-65C1BBF8-750E-44E6-AA3A-22DEAD570A4FQ50419937-8AAFC08C-46C0-4202-96A7-258DE8F00F15Q51070660-3D8BE376-B112-42D6-A7B7-E1783CAADE7CQ54112511-0B2A11A3-ED44-423F-93EF-CCC2A7CB9E15Q54983740-E400B341-F15F-49D0-BFCB-61F5FDF08503Q55315303-AC74A1A0-E3AA-4753-B6F1-E6C613BD3AA6
P2860
RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
RIPK3-mediated necroptosis pro ...... nd reduces allograft survival.
@en
RIPK3-mediated necroptosis pro ...... nd reduces allograft survival.
@nl
type
label
RIPK3-mediated necroptosis pro ...... nd reduces allograft survival.
@en
RIPK3-mediated necroptosis pro ...... nd reduces allograft survival.
@nl
prefLabel
RIPK3-mediated necroptosis pro ...... nd reduces allograft survival.
@en
RIPK3-mediated necroptosis pro ...... nd reduces allograft survival.
@nl
P2093
P2860
P356
P1476
RIPK3-mediated necroptosis pro ...... nd reduces allograft survival.
@en
P2093
A M Jevnikar
A Pavlosky
P2860
P304
P356
10.1111/AJT.12447
P407
P577
2013-09-18T00:00:00Z